Skip to main content
Download PDF

Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy

BMC Cancer volume 18, Article number: 413 (2018) Cite this article

The Original Article was published on 27 February 2018

Correction

It has been highlighted that in the original manuscript [1] Table S3 ‘An example of the predictive computational modeling process. Specific details on an annexure section of the PD-L1 pathway show the step-by-step reactions, mechanisms, and reaction equations that occur. Such reactions also occurred in all of the other pathways’ was omitted and did not appear in the Additional files. The original article has been updated.

Reference

  1. Brogden KA, et al. Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy. BMC Cancer. 2018;18:225. https://doi.org/10.1186/s12885-018-4134-y.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Iowa Institute for Oral Health Research, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, IA, 52242, USA

    Kim A. Brogden & Fang Qian

  2. Cellworks Research India Ltd., Whitefield, Bangalore, 560066, India

    Deepak Parashar

  3. Biomedical Engineering, The University of Iowa, 5318 SC, Iowa City, IA, 52242, USA

    Andrea R. Hallier & Terry Braun

  4. Division of Biostatistics and Research Design, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, IA, 52242, USA

    Fang Qian

  5. Division of Hematology/Oncology, Columbia University Medical Center, 177 Fort Washington Avenue, New York, NY, 10032, USA

    Naiyer A. Rizvi

  6. Molecular Pathology Laboratory, Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., C606GH, Iowa City, IA, 52242, USA

    Aaron D. Bossler

  7. Clinical Services, Experimental Therapeutics, Melanoma and Sarcoma Program, Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, 52242, USA

    Mohammed M. Milhem

  8. Department of Radiation Oncology, Human Oncology and Pathogenesis Program, Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA

    Timothy A. Chan

  9. Cellworks Group, Inc., 2033 Gateway Place Suite 500, San Jose, CA, 95110, USA

    Taher Abbasi & Shireen Vali

Authors
  1. Kim A. Brogden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deepak Parashar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea R. Hallier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Terry Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fang Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naiyer A. Rizvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aaron D. Bossler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mohammed M. Milhem
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Timothy A. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Taher Abbasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shireen Vali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kim A. Brogden.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brogden, K.A., Parashar, D., Hallier, A.R. et al. Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy. BMC Cancer 18, 413 (2018). https://doi.org/10.1186/s12885-018-4200-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12885-018-4200-5

BMC Cancer

ISSN: 1471-2407

Contact us